Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia.

Huang, Zhenli; Yan, Han; Teng, Yao; Shi, Wei; Xia, Linghui

Huang, Zhenli; Yan, Han; Teng, Yao; Shi, Wei; Xia, Linghui.

Afiliação

Huang Z; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yan H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Teng Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shi W; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xia L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Front Immunol ; 13: 1017850, 2022.

Article em En | MEDLINE | ID: mdl-36458000

Assuntos

Infecções por Citomegalovirus; Doença Enxerto-Hospedeiro; Transplante de Células-Tronco Hematopoéticas; Humanos; Doença Enxerto-Hospedeiro/etiologia; Doença Enxerto-Hospedeiro/prevenção & controle; Basiliximab; Soro Antilinfocitário/uso terapêutico; Viremia; Estudos Retrospectivos; Recidiva Local de Neoplasia; Transplante de Células-Tronco Hematopoéticas/efeitos adversos

Palavras-chave

ATG; GVHD prophylaxis; basiliximab; haploidentical HSCT; hematologic malignancies

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google